pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
209
stories
14h
Capricor CEO won’t rule out legal action against FDA after negative adcomm
biospace
16h
Lilly and Resilience invest $750M in diabetes and obesity drug device supply
biospace
1d
Opinion: We once praised the American Diabetes Association’s courage. How things have changed
stat
1d
Alnylam plunges as earnings deliver ‘one-two punch’
biopharma dive
1d
Chutes & Ladders—Legend CEO departs without successor in place
fiercebiotech
1d
J&J secures right to take the helm in up to $925M Sail CAR T pact
biospace
2d
Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases
stat
2d
New funding, new jobs: 4 biotechs hiring after series B raises
biospace
2d
Is it safe to drink Red Bull and alcohol? Questionable research tied to energy drink giant has shaped policy
stat
2d
FDA advisers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
2d
FDA reviewers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting
biospace
2d
NSF testing new Ph.D. model giving trainees academic and industry experience
stat
2d
Capricor Duchenne cell therapy voted down by FDA panel
biopharma dive
2d
AbCellera, Vertex partner on next-gen T-cell engagers
biopharma dive
2d
Biogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectations
biospace
2d
Merck posts—then pulls—trial plan for PD-1xVEGF and TROP2 ADC combination
fiercebiotech
2d
STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
stat
2d
STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
stat
2d
Incyte cuts early-stage cancer drug to focus on next-gen programs
biospace
2d
GSK cost-cutting plan includes global layoffs
biospace
2d
Former Recursion CEO Chris Gibson joins Dimension as operating partner
endpoints
3d
Opinion: The VA could help America win the biotechnology race with China
stat
3d
STAT+: In the biotech industry, a most-wanted fugitive was long hiding in plain sight
stat
3d
Vertex’s latest autoimmune TCE play involves $28M upfront to AbCellera
fiercebiotech
3d
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
3d
Webinar: Building the Intelligence Engine for Drug Discovery R&D Teams
biospace
3d
FDA offers updated guidance for generics of weight loss blockbusters
endpoints
3d
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
3d
An eye drug biotech banks $118M and stocks its executive suite
biopharma dive
4d
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
fiercebiotech
← prev
page 1 of 7
next →
